Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial ...Middle East

WIXOM, Mich., May 12, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that it provided the U.S. Food and Drug Administration (FDA) with the...

Hence then, the article about rockwell medical submits supplemental data to fda for ind application for phase 2 fpc home infusion trial was published today ( Thursday 12/05/2022 - 03:10 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial )

Also on site :

• Travis County deputy arrested on official oppression charge
• Why have the US and Israel bombed more than 75 Iranian police facilities?
• 10 Shows Like 'Your Friends and Neighbors' You Should Watch Next